Abstract
After an explanation of alternative treatment modalities, 30 patients with unresectable liver metastases from colorectal adenocarcinoma chose to have no treatment. Fourteen patients (47 percent) had synchronous liver metastases and 16 (53 percent) had metachronous lesions. Thirteen of the 30 patients (43 percent) had histologic documentation of liver metastases, with the remaining 17 patients diagnosed by liver scan, ultrasonography, or computerized axial tomography. Twenty-four of 30 patients (80%) had less than 25 percent liver involvement (Stage I), 23 of 24 patients had alkaline phosphatase levels less than twice normal, and 20 of 24 patients were asymptomatic from their liver metastases. The remaining six patients had liver stages II or III at the time of diagnosis. Overall mean survival of the 30 reported patients with untreated metastatic colorectal cancer to liver is 16 months (range, 2 to 58 months; median survival, 12 months).
Similar content being viewed by others
References
Welch J, Donaldson G. The clinical correlation of an autopsy study of recurrent colorectal cancer. Ann Surg 1979;189:496–502.
Petrelli NJ, Barcewicz PA, Evans J, Ledesma E, Lawrence D, Mittelman A. Hepatic artery ligation for liver metastases in colorectal carcinoma. Cancer 1984;53:1347–53.
Shepard KV, Levin B, Karl R, et al. Therapy for metastatic colorectal cancer with hepatic artery infusion chemotherapy using a subcutaneous implanted pump. J Clin Oncol 1985; 3:161–9.
Moertel CG. Chemotherapy of gastrointestinal cancer. N Engl J Med 1978;299:1049–52.
Goslin R, Steele G Jr, Zamcheck N, Mayer R, MacIntyre J. Factors influencing survival in patients with hepatic metastases from adenocarcinoma of the colon or rectum. Dis Colon Rectum 1982;25:749–54.
Petrelli NJ, Bonnheim DC, Herrera LO, Mittelman A. A proposed classification system for liver metastasis from colorectal carcinoma. Dis Colon Rectum 1984;27:249–52.
Herrera-Ornelas L, Justiniano J, Castillo N, Petrelli N, Stulc J, Mittelman A. Metastases in small lymph nodes from colon cancer. Arch Surg 1987;122:1253–6.
Jaffe BM, Donegan W, Watson F, Spratt JS, Jr. Factors influencing survival in patients with untreated hepatic metastases. Surg Gynecol Obstet 1968;127:1–11.
Author information
Authors and Affiliations
About this article
Cite this article
Palmer, M., Petrelli, N.J. & Herrera, L. No treatment option for liver metastases from colorectal adenocarcinoma. Dis Colon Rectum 32, 698–701 (1989). https://doi.org/10.1007/BF02555777
Issue Date:
DOI: https://doi.org/10.1007/BF02555777